Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-Phospho-EGFR-Y1045 antibody (STJ117917) | Login | Anti-Phospho-EGFR-Y1045 antibody (STJ117917) | ||||||||||||||||
|
||||||||||||||||||
Anti-Phospho-EGFR-Y1086 antibody (STJ117918) | Login | Anti-Phospho-EGFR-Y1086 antibody (STJ117918) | ||||||||||||||||
|
||||||||||||||||||
Anti-Phospho-CRK-Y221 antibody (STJ117920) | Login | Anti-Phospho-CRK-Y221 antibody (STJ117920) | ||||||||||||||||
|
||||||||||||||||||
Anti-Phospho-AP2M1-T156 antibody (STJ117921) | Login | Anti-Phospho-AP2M1-T156 antibody (STJ117921) | ||||||||||||||||
|
||||||||||||||||||
Anti-Phospho-CRKL-Y207 antibody (STJ117922) | Login | Anti-Phospho-CRKL-Y207 antibody (STJ117922) | ||||||||||||||||
|
||||||||||||||||||
Anti-Phospho-POLR2A-S5 antibody (STJ117926) | Login | Anti-Phospho-POLR2A-S5 antibody (STJ117926) | ||||||||||||||||
|
||||||||||||||||||
Anti-MPL antibody (295-390) (STJ119126) | Login | Anti-MPL antibody (295-390) (STJ119126) | ||||||||||||||||
|
||||||||||||||||||
Anti-EPS15L1 antibody (350-430 aa) (STJ190299) | Login | Anti-EPS15L1 antibody (350-430 aa) (STJ190299) | ||||||||||||||||
|
||||||||||||||||||
Anti-HJURP antibody (80-160 aa) (STJ190300) | Login | Anti-HJURP antibody (80-160 aa) (STJ190300) | ||||||||||||||||
|
||||||||||||||||||
Anti-FAT1 antibody (1140-1220 aa) (STJ190301) | Login | Anti-FAT1 antibody (1140-1220 aa) (STJ190301) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGF10 antibody (120-200 aa) (STJ190302) | Login | Anti-FGF10 antibody (120-200 aa) (STJ190302) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGF21 antibody (90-170 aa) (STJ190303) | Login | Anti-FGF21 antibody (90-170 aa) (STJ190303) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGFBP3 antibody (110-190 aa) (STJ190304) | Login | Anti-FGFBP3 antibody (110-190 aa) (STJ190304) | ||||||||||||||||
|
||||||||||||||||||
Anti-FRAT1 antibody (130-210 aa) (STJ190306) | Login | Anti-FRAT1 antibody (130-210 aa) (STJ190306) | ||||||||||||||||
|
||||||||||||||||||
Anti-GTSE1 antibody (70-150 aa) (STJ190308) | Login | Anti-GTSE1 antibody (70-150 aa) (STJ190308) | ||||||||||||||||
|
||||||||||||||||||
Anti-IGF2BP1 antibody (10-90 aa) (STJ190314) | Login | Anti-IGF2BP1 antibody (10-90 aa) (STJ190314) | ||||||||||||||||
|
||||||||||||||||||
Anti-IFIT2 antibody (200-280 aa) (STJ190316) | Login | Anti-IFIT2 antibody (200-280 aa) (STJ190316) | ||||||||||||||||
|
||||||||||||||||||
Anti-IFIT3 antibody (330-410 aa) (STJ190317) | Login | Anti-IFIT3 antibody (330-410 aa) (STJ190317) | ||||||||||||||||
|
||||||||||||||||||
Anti-IFIT1B antibody (10-90 aa) (STJ190330) | Login | Anti-IFIT1B antibody (10-90 aa) (STJ190330) | ||||||||||||||||
|
||||||||||||||||||
Anti-ITFG2 antibody (40-120 aa) (STJ190342) | Login | Anti-ITFG2 antibody (40-120 aa) (STJ190342) | ||||||||||||||||
|
||||||||||||||||||
Anti-KDM5A antibody (720-800 aa) (STJ190343) | Login | Anti-KDM5A antibody (720-800 aa) (STJ190343) | ||||||||||||||||
|
||||||||||||||||||
Anti-KRT35 antibody (340-420 aa) (STJ190351) | Login | Anti-KRT35 antibody (340-420 aa) (STJ190351) | ||||||||||||||||
|
||||||||||||||||||
Anti-KRT83 antibody (50-130 aa) (STJ190357) | Login | Anti-KRT83 antibody (50-130 aa) (STJ190357) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA4 antibody (70-150 aa) (STJ190358) | Login | Anti-MAGEA4 antibody (70-150 aa) (STJ190358) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA10 antibody (70-150 aa) (STJ190359) | Login | Anti-MAGEA10 antibody (70-150 aa) (STJ190359) | ||||||||||||||||
|